Envoy Medical, Inc. (COCH) Expected to Beat Earnings Estimates: Should You Buy?

Envoy Medical, Inc. (COCH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

AVITA Medical Announces CEO Transition

VALENCIA, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (“AVITA Medical”, or the “Company”), a leading therapeutic acute wound care company, today announced that the Board of Directors has named Chairman of the Board Cary Vance as Interim Chief Executive Officer, effective immediately. In conjunction with this appointment, Jim Corbett is leaving his positions as CEO and member of the Board. Mr. Vance will continue to serve as Chairman of the Board, whil...

ICU Medical (ICUI) Surpasses Q2 Earnings and Revenue Estimates

ICU Medical (ICUI) delivered earnings and revenue surprises of +45.83% and +0.55%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

ICU Medical, Inc. 2025 Q1 - Results - Earnings Call Presentation

ICU Medical (ICUI) Q1 Earnings and Revenues Beat Estimates

ICU Medical (ICUI) delivered earnings and revenue surprises of 39.84% and 5.54%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

ICUI Stock Gains Following Latest FDA Approvals for Precision IV Pumps

ICU Medical aims to enable healthcare systems to customize infusion setups, optimizing device footprint without compromising performance or safety.

ICU Medical, Inc. (ICUI) Q4 2024 Earnings Call Transcript

ICU Medical (ICUI) Q4 Earnings and Revenues Top Estimates

ICU Medical (ICUI) delivered earnings and revenue surprises of 42.57% and 3.95%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

ICU Medical to Present at the Raymond James 46th Annual Institutional Investors Conference

SAN CLEMENTE, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the Raymond James 46th Annual Institutional Investors Conference being held in Orlando, Florida, March 3-5, 2025. ICU Medical’s presentation will be on Monday, March 3, 2025 at 5:40 a.m. PT (8:40 a.m. ET). Company management will also be participating in one-on-one meetings on...

ICU Medical Announces Time of Fourth Quarter 2024 Earnings Conference Call

SAN CLEMENTE, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its fourth quarter 2024 earnings release and conference call.

U.S. External Analgesics Research Report 2024-2030: Hot/Cold Products, Kinesiology Tape, TENS Devices, and Infrared Therapy Products Size, Share & Trends Analysis

Dublin, Sept. 06, 2024 (GLOBE NEWSWIRE) -- The "U.S. External Analgesics Market Size, Share & Trends Analysis Report by Product (Hot/Cold Products, Kinesiology Tape, TENS Devices, and Infrared Therapy Products), Distribution Channel, and Segment Forecasts, 2024-2030" report has been added to ResearchAndMarkets.coms offering.The U.S. external analgesics market size is anticipated to reach USD 6.66 billion by 2030 and is projected to grow at the CAGR of 13.1% from 2024 to 2030. The increasing ...

ICU Medical Inc (ICUI) Q2 2024 Earnings Call Transcript

Germany Syringe Market Forecasts Report 2024: A $489.4 Million Market by 2029 Featuring Major Players - BD, B. Braun Melsungen, Terumo, Teleflex, Nipro, ICU Medical, and Cardinal Health

Dublin, July 22, 2024 (GLOBE NEWSWIRE) -- The "Germany Syringe Market - Forecasts from 2024 to 2029" report has been added to ResearchAndMarkets.coms offering.The German syringe market is expected to experience a CAGR of 3.69% throughout the forecast period, reaching a market size of US$489.542 million by 2029. This represents a substantial increase from US$379.966 million recorded in 2022

Respiratory Care Market to Top $49.84 Billion by 2031: Coherent Market Insights, Inc

The global respiratory care market, valued at $25.95 billion in 2024, is on a trajectory of rapid expansion, with projections indicating it will soar to $49.84 billion by 2031, as per a recent report by Coherent Market Insights. Companies covered: Medtronic, Koninklijke Philips N.V., ICU Medical, Inc., Teleflex Incorporated, ResMed, Dragerwerk AG & Co. KGaA, Belluscura, VYAIRE, Medline Industries, OMRON Corporation, Xplore Health Technologies Pvt. Ltd., Masimo, Fisher & Paykel Healthcare Limited...

ICU Medical, Inc. (ICUI) Q1 2024 Earnings Call Transcript

ICU Medical, Inc. 2024 Q1 - Results - Earnings Call Presentation

ICU Medical Announces Time of First Quarter 2024 Earnings Conference Call

SAN CLEMENTE, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its first quarter 2024 earnings release and conference call.

Global Voice Prosthesis Devices Market Size To Worth USD 2.29 Billion By 2033 | CAGR of 5.51%

The Global Voice Prosthesis Devices Market Size was Valued at USD 1.34 Billion in 2023 and the Worldwide Voice Prosthesis Devices Market Size is Expected to Reach USD 2.29 Billion by 2033, according to a research report published by Spherical Insights & Consulting. Companies covered: Andreas Fahl Medizintechnik-Vertrieb GmbH, HEIMOMED Heinze GmbH & Co. KG, Hood Laboratories, ICU Medical, Inc., InHealth Technologies, Innaumation Medical Devices Private Limited, Atos Medical, Luminaud, Inc., Servo...

ICU medical exec sells over $77k in company stock By Investing.com

ICU medical exec sells over $77k in company stock

ICU Medical to Present at the KeyBanc Life Sciences & MedTech Investor Forum

SAN CLEMENTE, Calif., March 13, 2024 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the KeyBanc Life Sciences & MedTech Investor Forum being held virtually March 19-20, 2024. ICU Medical’s presentation will be on Wednesday, March 20, 2024 at 11:15 a.m. PT (2:15 p.m. ET). Company management will also be participating in one-on-one meetings on Wednesday, March...

Earnings call: ICU Medical reports steady growth and 2024 outlook By Investing.com

Earnings call: ICU Medical reports steady growth and 2024 outlook

ICU Medical, Inc. (ICUI) Q4 2023 Earnings Call Transcript